Meet the Professor
ITMIG 2017—Prof. Patrick Loehrer: conduct more clinical trials to get more helpful information and benefits patients
Mediastinum
2017;
1:
22
(30 November 2017)
Editorial
Single missense mutation as a signal of indolent thymic epithelial tumors: General Transcription Factor II-I (GTF2I)
Mediastinum
2017;
1:
20
(29 November 2017)
Editorial
Lymph nodes metastases in thymic malignancies: we need prospective studies
Mediastinum
2017;
1:
19
(25 November 2017)
Editorial
GTF2I gene mutation—a driver of thymoma pathogenesis
Mediastinum
2017;
1:
18
(25 November 2017)
Editorial
Optimal therapy for thymic epithelial tumors with pleural involvement
Mediastinum
2017;
1:
17
(17 November 2017)
Editorial
Balance between less invasiveness and radical capability with safety
Mediastinum
2017;
1:
15
(03 November 2017)
Editorial
Editorial on “assessment of the ITMIG statement on the WHO histological classification and of the 8th TNM staging of thymic epithelial tumors, of a series of 188 thymic epithelial tumors”
Mediastinum
2017;
1:
14
(03 November 2017)
Review Article
Induction chemoradiotherapy for unresectable thymic tumors
Mediastinum
2017;
1:
13
(29 October 2017)
Editorial
Thymic tumours with pleural involvement: does surgery play a role in this orphan disease?
Mediastinum
2017;
1:
12
(29 October 2017)
Editorial
Nonintubated single port video-assisted thoracoscopic thymectomy: a promising future of treatment
Mediastinum
2017;
1:
11
(29 October 2017)
Review Article
Overview of the pathology of thymic neuroendocrine tumors
Mediastinum
2017;
1:
10
(20 October 2017)
Review Article
Evolution of thymic malignancy management in Japan
Mediastinum
2017;
1:
9
(14 October 2017)
Poster Session 2
AB056. PS02.20: Left sided VATS + subxiphoid for radical thymectomy
Mediastinum
2017;
1:
AB056
(12 September 2017)
Poster Session 2
AB055. PS02.19: Should pulmonary metastasectomy be performed in the thymoma?
Mediastinum
2017;
1:
AB055
(12 September 2017)
Poster Session 2
AB054. PS02.18: Thymic epithelial tumours and additional malignancies: an unresolved enigma
Mediastinum
2017;
1:
AB054
(12 September 2017)
Poster Session 2
AB053. PS02.17: The TYME network of expert centres presents the first Italian consensus conference for thymic epithelial tumours
Mediastinum
2017;
1:
AB053
(12 September 2017)
Poster Session 2
AB052. PS02.16: Minimally invasive treatment by robotic surgery of thymoma B2 stage IVA
Mediastinum
2017;
1:
AB052
(12 September 2017)
Poster Session 2
AB051. PS02.15: Results of extended thymectomy in thymomatous myasthenia gravis
Mediastinum
2017;
1:
AB051
(12 September 2017)
Poster Session 2
AB050. PS02.14: Interference of myasthenia gravis (MG) with long term prognosis of thymoma
Mediastinum
2017;
1:
AB050
(12 September 2017)
Poster Session 2
AB049. PS02.13: Platinum based chemotherapy in locally advanced non-metastatic thymic carcinoma
Mediastinum
2017;
1:
AB049
(12 September 2017)
Poster Session 2
AB048. PS02.12: Pre-operative CT staging is an accurate predictor of post-operative histological staging
Mediastinum
2017;
1:
AB048
(12 September 2017)
Poster Session 2
AB047. PS02.11: Thymic mesenchymal neoplasia: a single institution experience
Mediastinum
2017;
1:
AB047
(12 September 2017)
Poster Session 2
AB046. PS02.10: ROBOTIC thymectomy for early stage thymoma: single center experience
Mediastinum
2017;
1:
AB046
(12 September 2017)
Poster Session 2
AB045. PS02.09: Video-assisted thoracic surgery for thymoma: long-term follow up results and prognostic factors
Mediastinum
2017;
1:
AB045
(12 September 2017)
Poster Session 2
AB044. PS02.08: Surgery for TET in the era of translational research: towards a workflow model incorporating the biobank
Mediastinum
2017;
1:
AB044
(12 September 2017)
Poster Session 2
AB043. PS02.07: Features of thymoma-associated myasthenia gravis: a retrospective analysis on 346 patients
Mediastinum
2017;
1:
AB043
(12 September 2017)
Poster Session 2
AB042. PS02.06: Early outcomes and hospital stay following surgery for thymic masses—robotic versus open surgery
Mediastinum
2017;
1:
AB042
(12 September 2017)
Poster Session 2
AB041. PS02.05: Predictive value of 18FDG-PET/CT on preoperative management of thymic tumours
Mediastinum
2017;
1:
AB041
(12 September 2017)
Poster Session 2
AB040. PS02.04: DOTATATE PET/CT in thymic atypical carcinoid tumor with secondary ACTH-dependent Cushing’s syndrome
Mediastinum
2017;
1:
AB040
(12 September 2017)
Poster Session 2
AB039. PS02.03: The risk of developing extrathymic malignancies in patients with thymoma after surgery
Mediastinum
2017;
1:
AB039
(12 September 2017)
Poster Session 2
AB038. PS02.02: Proposal for refined classification of thymectomy
Mediastinum
2017;
1:
AB038
(12 September 2017)
Poster Session 2
AB037. PS02.01: Is it necessary a superpower to detect thymoma?
Mediastinum
2017;
1:
AB037
(12 September 2017)
Poster Session 1
AB036. PS01.18: Thymoma: a review of the clinical and pathological findings in 66 cases
Mediastinum
2017;
1:
AB036
(12 September 2017)
Poster Session 1
AB035. PS01.17: Primary thymic adenocarcinoma with signet ring cell features to a 39-year-old male: a case report
Mediastinum
2017;
1:
AB035
(12 September 2017)
Poster Session 1
AB034. PS01.16: A case of thymic cyst with papillary proliferation of ciliated epithelium
Mediastinum
2017;
1:
AB034
(12 September 2017)
Poster Session 1
AB033. PS01.15: Relevance of adhesion molecules for killing of thymoma and thymic carcinoma
Mediastinum
2017;
1:
AB033
(12 September 2017)
Poster Session 1
AB032. PS01.14: Epithelial tumours of the thymus: experience with a national database on prognostic factors and treatment
Mediastinum
2017;
1:
AB032
(12 September 2017)
Poster Session 1
AB031. PS01.13: Clinicopathological characteristics and prognostic factors of patients with thymic carcinoma
Mediastinum
2017;
1:
AB031
(12 September 2017)